Pharmacists as providers: Targeting pneumococcal vaccinations to high risk populations
Open Access
- 19 October 2011
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 29 (45), 8073-8076
- https://doi.org/10.1016/j.vaccine.2011.08.051
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Healthcare utilization and cost of pneumococcal disease in the United StatesVaccine, 2011
- Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in JapanVaccine, 2010
- Clinical and economic burden of pneumococcal disease in older US adultsVaccine, 2010
- Higher Pneumococcal Disease Vaccination Rates Needed to Protect More At-Risk US AdultsPostgraduate Medicine, 2009
- Streptococcus pneumoniae: Epidemiology, Risk Factors, and Strategies for PreventionSeminars in Respiratory and Critical Care Medicine, 2009
- Alternative strategies for adult pneumococcal polysaccharide vaccination: A cost-effectiveness analysisVaccine, 2008
- Increasing Prevalence of Multidrug-ResistantStreptococcus pneumoniaein the United StatesThe New England Journal of Medicine, 2000
- Relation between Influenza Vaccination and Outpatient Visits, Hospitalization, and Mortality in Elderly Persons with Chronic Lung DiseaseAnnals of Internal Medicine, 1999
- Cost-effectiveness of Vaccination Against Pneumococcal Bacteremia Among Elderly PeoplePublished by American Medical Association (AMA) ,1997
- Clinical Efficacy of Pneumococcal Vaccine in the ElderlyAmerican Journal Of Medicine, 1997